SCHEMBL5186285

SCHEMBL5186285

CCCCCCCCCCCCCC(C)C(C)(C)C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
PRSS1 P07477 3/20 0.45
CTSG P08311 3/20 0.45
CTRB1 P17538 3/20 0.45
CMA1 P23946 3/20 0.45
CA2 P00918 2/20 0.42
CA1 P00915 2/20 0.42
ABCB1 P08183 1/20 0.41
MEN1 O00255 1/20 0.41
HPGD P15428 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FAAH O00519 4/20 0.41
ACE2 Q9BYF1 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
GPR84 Q9NQS5 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7613397 1.00 ZDHHC7 (0.47) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL18097883 1.00 ZDHHC7 (0.47) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL8976729 1.00 ZDHHC7 (0.47) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL27553218 1.00 ZDHHC7 (0.47) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL5167002 1.00 ZDHHC7 (0.47) ZDHHC7USP2LMNAPRSS1CTSG
Hydrochloric Acid SCHEMBL28052365 0.98 ZDHHC7 (0.46) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL22573795 0.98 PRSS1 (0.46) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL1114582 0.93 CA2 (0.48) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL27273846 0.86 ZDHHC7 (0.47) ZDHHC7USP2LMNAPRSS1CTSG
SCHEMBL3724149 0.85 CA1 (0.38) ZDHHC7USP2LMNAPRSS1CTSG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101795701-A Inhibitors of acetyl COA carboxylase for the treatment of neuronal hypometabolism ACCERA INC 2010-08-04 CN claimed
CN-107666904-B Purified composition of polyunsaturated fatty acids, method for preparing same and use thereof 提贝托·布鲁泽塞 2022-02-01 CN disclosed
US-11154525-B2 Purified compositions of polyunsaturated fatty acids, their preparation method and their use BRUZZESE TIBERIO (IT) 2021-10-26 US disclosed
CN-107261148-B Methylphenidate prodrugs, methods of making and using the same 凯姆制药公司 2021-07-13 CN disclosed
US-20200397734-A1 PURIFIED COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS, THEIR PREPARATION METHOD AND THEIR USE BRUZZESE TIBERIO (IT) 2020-12-24 US disclosed
US-10821090-B2 Purified compositions of polyunsaturated fatty acids, their preparation method and their use BRUZZESE TIBERIO (IT) 2020-11-03 US disclosed
EP-3273954-B1 PURIFIED COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS, THEIR PREPARATION METHOD AND THEIR USE BRUZZESE TIBERIO (IT) 2020-10-28 EP disclosed
EP-3526803-A1 ARRAY OF LIGHT SENSITIVE MEMBRANES BASED ON PHOSPHOLIPIDS Oxford University Innovation Limited (GB) 2019-08-21 EP disclosed
WO-2018219478-A1 HETEROARYL-CARBOXAMIDES AS HISTONE DEMETHYLASE INHIBITORS ORYZON GENOMICS, S.A. (ES) 2018-12-06 WO disclosed
WO-2018073583-A1 ARRAY OF LIGHT SENSITIVE MEMBRANES BASED ON PHOSPHOLIPIDS OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2018-04-26 WO disclosed
US-20060167096-A1 Livestock products with an increased ppar/rxr heterodimer activator level INVE TECHNOLOGIES NV (BE) 2006-07-27 US disclosed
EP-1638410-A1 LIVESTOCK PRODUCTS WITH AN INCREASED PPAR/RXR HETERODIMER ACTIVATOR LEVEL International Engineering and Trading, afgekort I.E.T. (BE) 2006-03-29 EP disclosed
WO-2005000036-A1 LIVESTOCK PRODUCTS WITH AN INCREASED PPAR/RXR HETERODIMER ACTIVATOR LEVEL INTERNATIONAL ENGINEERING AND TRADING, AFGEKORT I.E.T. (BE) 2005-01-06 WO disclosed
WO-2004072046-A2 QUINOLINE DERIVATIVES AND THEIR USE FOR MODULATION OF LXR ACTIVITY CAREX S.A. (FR) 2004-08-26 WO disclosed
WO-2004072042-A2 QUINOLINE DERIVATIVE AND THEIR USE FOR MODULATION OF LXR ACTIVITY CAREX S.A. (FR) 2004-08-26 WO disclosed
WO-2004072041-A1 TETRAHYDROQUINOLINES AS AGONISTS OF LIVER- X RECEPTORS CARE X S.A. (FR) 2004-08-26 WO disclosed
WO-2004043951-A1 PYRAZOLE DERIVATIVES AS MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS CAREX S.A. (FR) 2004-05-27 WO disclosed
WO-2004037248-A2 MODULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ACTIVITY CAREX SA (FR) 2004-05-06 WO disclosed
EP-1051180-A1 PHOSPHOLIPIDS HAVING ANTIMICROBIAL ACTIVITY WITH OR WITHOUT THE PRESENCE OF ANTIMICROBIALS STATENS SERUMINSTITUT (DK) 2000-11-15 EP disclosed
WO-1999026632-A1 PHOSPHOLIPIDS HAVING ANTIMICROBIAL ACTIVITY WITH OR WITHOUT THE PRESENCE OF ANTIMICROBIALS STATENS SERUM INSTITUT (DK) 1999-06-03 WO disclosed